US20020007106A1 - Intra-viginal device - Google Patents
Intra-viginal device Download PDFInfo
- Publication number
- US20020007106A1 US20020007106A1 US09/197,736 US19773698A US2002007106A1 US 20020007106 A1 US20020007106 A1 US 20020007106A1 US 19773698 A US19773698 A US 19773698A US 2002007106 A1 US2002007106 A1 US 2002007106A1
- Authority
- US
- United States
- Prior art keywords
- base
- vaginal wall
- back portion
- posterior
- urethra
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F6/00—Contraceptive devices; Pessaries; Applicators therefor
- A61F6/06—Contraceptive devices; Pessaries; Applicators therefor for use by females
- A61F6/08—Pessaries, i.e. devices worn in the vagina to support the uterus, remedy a malposition or prevent conception, e.g. combined with devices protecting against contagion
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/0004—Closure means for urethra or rectum, i.e. anti-incontinence devices or support slings against pelvic prolapse
- A61F2/0031—Closure means for urethra or rectum, i.e. anti-incontinence devices or support slings against pelvic prolapse for constricting the lumen; Support slings for the urethra
- A61F2/005—Closure means for urethra or rectum, i.e. anti-incontinence devices or support slings against pelvic prolapse for constricting the lumen; Support slings for the urethra with pressure applied to urethra by an element placed in the vagina
Definitions
- the present invention relates to intra-vaginal devices to aid in controlling urinary incontinence.
- U.S. Pat. No. 4,139,006 Disclosed in U.S. Pat. No. 4,139,006 is an intra-vaginal device for controlling urinary incontinence in female patients.
- the device is slightly arcuate so as to have slightly raised anterior and posterior vaginal wall engaging portions with a lower central aperture.
- the anterior portion has a pair of projections generally within the plane of the device which engage the vaginal wall to apply pressure to the urethra, to close the urethra.
- U.S. Pat. Nos. 5,036,867 and 4,920,986 also disclose intra-vaginal devices to aid in controlling urinary incontinence. However, these devices are arcuate in the opposite direction tot he previous device and engage the anterior vaginal wall to cradle the bladder neck. The urethra is not closed.
- U.S. Pat. No. 4,920,986 discloses a modification of the previous two devices but again the device cradles the bladder neck.
- an intra-vaginal device to aid in controlling urinary incontinence comprising:
- a base to extend between the anterior vaginal wall and the posterior vaginal wall of a patient, so as to apply pressure thereto, said base having a forward convex surface to engage the anterior vaginal wall to support and elevate the anterior vaginal wall and urethra without occluding the urethra, and a rear part to engage the posterior vaginal wall;
- a back portion extending from said rear part so that in use it extends therefrom towards the cervix and is supported on the pelvic floor so as to distribute the pressure applied to the posterior wall.
- FIG. 1 is a schematic perspective view of an intra-vaginal device to aid in controlling urinary incontinence
- FIG. 2 is a schematic top plan view of the device of FIG. 1; 2 .
- FIG. 3 is a schematic end elevation of the device of FIG. 1;
- FIG. 4 is a schematic side elevation of the device of FIG. 1;
- FIG. 5 is a schematic perspective view of a modified form of the device of FIG. 1;
- FIG. 6 is a schematic top plan view of the device of FIG. 5;
- FIG. 7 is a schematic end elevation of the device of FIG. 5;
- FIG. 8 is a schematic side elevation of the device of FIG. 5;
- FIG. 9 is a schematic perspective view of a further device to aid in controlling urinary incontinence
- FIG. 10 is a schematic side elevation of the device of FIG. 9;
- FIG. 11 is a schematic top plan view of the device of FIG. 9;
- FIG. 12 is a schematic end elevation of the device of FIG. 9;
- FIG. 13 is a schematic perspective view of a modified form of the device of FIG. 9;
- FIG. 14 is a schematic side elevation of the device of FIG. 13;
- FIG. 15 is a schematic top plan view of the device of FIG. 13;
- FIG. 16 is a schematic end elevation of the device of FIG. 13;
- FIG. 17 is a sagital abdominal cross-sectional view of a female patient illustrating the normal physiology of the bladder and urethra;
- FIG. 18 is a sagital abdominal cross-sectional view of an incontinent female patient with the bladder neck in a descended position
- FIG. 19 is a sagital abdominal cross-sectional view of the female patient of
- FIG. 18 showing the device of FIGS. 13 to 16 installed. 3 .
- FIGS. 1 to 8 of the accompanying drawings there is schematically depicted two intra-vaginal devices 30 to aid in controlling urinary incontinence.
- the devices 30 each include a base 31 having a forward arcuate part 32 with a forward convex surface 33 which engages the anterior wall to support and elevate the anterior vaginal wall and the urethra behind the vaginal wall. In that regard it should be appreciated that the devices 30 do not close the urethra.
- the base 31 is generally of a toroidal configuration and provides a rear part 34 and a central aperture 35 .
- a back portion 36 Extending generally normal (that is at a slight inclination) to the base 31 and from the rear part 34 is a back portion 36 which is also generally of a toroidal configuration and has a central aperture 37 .
- the base 31 and back portion 36 define a slightly obtuse included angle.
- the back portion 36 engages the posterior vaginal wall and is supported by the pelvic floor and projects generally toward the cervix from the base 31 .
- the base 31 extends between the posterior and anterior vaginal walls to apply supporting pressure thereto. The pressure applied to the posterior vaginal wall is distributed over the back portion 36 .
- the devices 30 would be formed of a resilient plastics material.
- FIGS. 1 to 8 The above described preferred embodiments described with reference to FIGS. 1 to 8 is particularly suited for use by women with incontinence and prolapse with a poor pelvic floor.
- the surface 33 is not only convex as a result of consisting of a curve extending about the center of the aperture 35 (as best seen in FIG. 7) but may also be convex in a plane generally perpendicular thereto as best seen in the cross section of FIG. 8.
- the base 31 has a length 48 of between 35 mm and 55 mm, preferably within the range of 40 mm to 50 mm.
- the base 31 should also have a depth 49 of 1 to 3 cm, preferably 1.5 to 2.5 cm.
- the base 31 should have a thickness 50 of 3 to 6 mm, preferably 4 to 5 mm.
- FIGS. 9 to 16 of the accompanying drawings there are schematically depicted intra-vaginal devices 40 to aid in controlling urinary incontinence.
- Each device 40 has a base 41 provided with an arcuate forward part 42 .
- the part 42 has a convex surface 43 which applies pressure to the anterior vaginal wall to support the vaginal wall and urethra therebehind.
- the base 31 is of a toroidal configuration having a central aperture 45 .
- a back portion 46 Projecting generally normal from the base 41 is a back portion 46 which is generally “oval” in configuration. That is it has elongated sides terminating with an upper arcuate portion.
- the back portion 46 has a central slot 47 .
- the base 41 is slightly inclined to the back portion 46 .
- the base 41 extends between the anterior and posterior vaginal walls to apply pressure thereto.
- the pressure applied to the posterior vaginal wall is distributed over the back portion 46 .
- the back portion 46 projects towards the cervix and is supported by the pelvic floor. 5 .
- the device of FIGS. 9 to 16 is suitable for younger women with prolapse and urinary incontinence.
- the surface 43 is not only convex as a result of consisting of a curve extending about the center of the aperture 35 (as best seen in FIG. 15) but may also be convex in a plane generally perpendicular thereto as best seen in FIG. 14.
- the base 41 has a length 48 of between 35 mm and 55 mm, preferably within the range of 40 mm to 50 mm.
- the base 41 should also have a depth 49 of 1 to 3 cm, preferably 1.5 to 2.5 cm.
- the base 41 should have a thickness 50 of 3 to 6 mm, preferably 4 to 5 mm.
- the rear surface 44 is also provided with an enlarged part 51 which is formed by shaping the rear surface 44 so as to be convex when viewed in side elevation (as best seen in FIG. 14).
- the rear surface 44 which engage the rear posterior vaginal wall, is also arcuate so as to be convex in a plane normal to the back portion 46 .
- the above two described embodiments address the surfaces 33 and 43 apply pressure to the anterior vaginal wall adjacent the urethra so as to support and elevate the anterior vaginal wall and urethra located therebehind. This support and elevation occurs without occluding the urethra.
- the dimensions 48 and 49 are arranged such that the force applied to 6 . the anterior vaginal wall is distributed to the extend that the urethra is not occluded but merely elevated and supported.
- FIG. 17 illustrates the normal anatomy of the urinary system of a female patient. Shown in FIG. 17 are the symphysis pubis 60 ; bladder 62 with bladder neck 64 ; urethra 66 ; pelvic floor 68 ; vagina 70 with anterior vaginal wall 72 and posterior vaginal wall 74 ; and uterus 76 . Above the pelvic floor 68 is the abdominal cavity 78 , with the vaginal cavity 80 lying below the pelvic floor.
- FIG. 17 is the position of the bladder neck 64 .
- the bladder 62 is located such that the bladder neck 64 is positioned above the pelvic floor 68 .
- the upper portion 84 of the urethra 66 lies within the abdominal cavity 78
- the lower portion 86 of the urethra lies within the vaginal cavity 80 .
- This transient pressure on the upper portion 84 of the urethra 66 balances the pressure exerted on the bladder 62 and thus helps prevent the leakage of urine despite transient increased bladder pressure.
- the bladder neck 64 has descended to a location at or below the pelvic floor 68 .
- the entire urethra 66 lies within the vaginal cavity 80 .
- condition illustrated in FIG. 18 can be either a static condition, such as when a cystocele condition exists, or a dynamic condition, which exists only in response to increased abdominal pressure.
- a static condition such as when a cystocele condition exists
- a dynamic condition which exists only in response to increased abdominal pressure.
- the normal position of the bladder neck 64 in the absence of increased abdominal pressure may resemble that shown in FIG. 18.
- the bladder neck 64 will momentarily descend to a location at or below the pelvic floor 68 , with the urine leakage consequences described above.
- FIG. 19 shows the device 40 installed to correct improper position of the urethra 66 . While the figures show the use of the device 40 , it is to be understood that the device 30 is installed and functions in the same general manner as to the device 40 .
- the back portion 46 of the device 40 rests on the posterior vaginal wall 74 .
- the length and configuration of the back portion 46 of the device prevents the device from rotating or otherwise becoming displaced within the vagina 70 .
- the lower end of the device 40 rests on the pelvic floor 68 .
- the convex forward surface 43 of the base 41 of the device displaces the anterior vaginal wall 72 forward and upward to support the urethra 66 .
- This support stabilises a hypermobile urethra such that the upper portion 84 of the urethra 66 is retained within the abdominal cavity 78 . Consequently, when a dynamic abdominal pressure is exerted, a portion of the abdominal pressure is applied against the upper portion 84 of the urethra 66 , which provides an additional force to offset transient 8 . bladder pressure increases.
- a device 40 in which the base 41 has a length 48 (see FIG. 14) of 35-55 millimeters, and most often 40-50 millimeters will elevate the anterior wall 72 of the vagina 70 sufficiently to support the urethra 66 in the desired position.
- the length 48 of the device 40 needed to accomplish this result will depend on the physiology of the particular female patient, such that devices having a height of greater than 55 millimeters or less than 35 millimeters may be necessary to elevate the anterior vaginal wall 72 to support the urethra 66 in the proper position without occluding it.
- the purpose of the devices 30 , 40 is to support the urethra 66 without occluding it. Since exerting a force at single point along the length of the urethra 66 tends to have an occlusive effect, it is desirable to spread the support along a length of the urethra. Since the length of the urethra 66 of an adult female tends to be approximately 3 centimeters, an effective depth 49 (FIG. 14) for the convex forward end 43 of the base 41 of the device 40 has been found to be approximately 2.5 centimeters.
- a device 30 , 40 having a forward edge 43 with a depth of as little as 1 centimeter may produce acceptable results, so long as the effect of the supporting edge is to elevate the urethra to a retropubic intra-abdominal position without occluding it. 9 .
Abstract
Description
- This is a continuation of International Application No. PCT/AU98/00183, filed Mar. 20,1998, the disclosure of which is incorporated herein by reference, which relies for priority on International Application No. PCT/AU97/00186, filed Mar. 20, 1997, Australian Provisional Application No. P08796, filed Aug. 27,1997 and Australian Provisional Application No. P09323, filed Sep. 19,1997.
- The present invention relates to intra-vaginal devices to aid in controlling urinary incontinence.
- Disclosed in U.S. Pat. No. 4,139,006 is an intra-vaginal device for controlling urinary incontinence in female patients. The device is slightly arcuate so as to have slightly raised anterior and posterior vaginal wall engaging portions with a lower central aperture. The anterior portion has a pair of projections generally within the plane of the device which engage the vaginal wall to apply pressure to the urethra, to close the urethra. U.S. Pat. Nos. 5,036,867 and 4,920,986 also disclose intra-vaginal devices to aid in controlling urinary incontinence. However, these devices are arcuate in the opposite direction tot he previous device and engage the anterior vaginal wall to cradle the bladder neck. The urethra is not closed. U.S. Pat. No. 4,920,986 discloses a modification of the previous two devices but again the device cradles the bladder neck.
- It is the object of the present invention to at least partly correct hypermobility and augment urethrae support.
- There is disclosed herein an intra-vaginal device to aid in controlling urinary incontinence, said device comprising:
- a base to extend between the anterior vaginal wall and the posterior vaginal wall of a patient, so as to apply pressure thereto, said base having a forward convex surface to engage the anterior vaginal wall to support and elevate the anterior vaginal wall and urethra without occluding the urethra, and a rear part to engage the posterior vaginal wall; and
- a back portion extending from said rear part so that in use it extends therefrom towards the cervix and is supported on the pelvic floor so as to distribute the pressure applied to the posterior wall.
- A preferred form of the present invention will now be described by way of example with reference to the accompanying drawings wherein:
- FIG. 1 is a schematic perspective view of an intra-vaginal device to aid in controlling urinary incontinence;
- FIG. 2 is a schematic top plan view of the device of FIG. 1;2.
- FIG. 3 is a schematic end elevation of the device of FIG. 1;
- FIG. 4 is a schematic side elevation of the device of FIG. 1;
- FIG. 5 is a schematic perspective view of a modified form of the device of FIG. 1;
- FIG. 6 is a schematic top plan view of the device of FIG. 5;
- FIG. 7 is a schematic end elevation of the device of FIG. 5;
- FIG. 8 is a schematic side elevation of the device of FIG. 5;
- FIG. 9 is a schematic perspective view of a further device to aid in controlling urinary incontinence;
- FIG. 10 is a schematic side elevation of the device of FIG. 9;
- FIG. 11 is a schematic top plan view of the device of FIG. 9;
- FIG. 12 is a schematic end elevation of the device of FIG. 9;
- FIG. 13 is a schematic perspective view of a modified form of the device of FIG. 9;
- FIG. 14 is a schematic side elevation of the device of FIG. 13;
- FIG. 15 is a schematic top plan view of the device of FIG. 13;
- FIG. 16 is a schematic end elevation of the device of FIG. 13;
- FIG. 17 is a sagital abdominal cross-sectional view of a female patient illustrating the normal physiology of the bladder and urethra;
- FIG. 18 is a sagital abdominal cross-sectional view of an incontinent female patient with the bladder neck in a descended position; and
- FIG. 19 is a sagital abdominal cross-sectional view of the female patient of
- FIG. 18 showing the device of FIGS.13 to 16 installed. 3.
- The following embodiments are modifications and/or improvements in the devices described in international Application PCT/AU97/00186.
- In FIGS.1 to 8 of the accompanying drawings there is schematically depicted two
intra-vaginal devices 30 to aid in controlling urinary incontinence. Thedevices 30 each include abase 31 having a forwardarcuate part 32 with aforward convex surface 33 which engages the anterior wall to support and elevate the anterior vaginal wall and the urethra behind the vaginal wall. In that regard it should be appreciated that thedevices 30 do not close the urethra. Thebase 31 is generally of a toroidal configuration and provides arear part 34 and acentral aperture 35. - Extending generally normal (that is at a slight inclination) to the
base 31 and from therear part 34 is aback portion 36 which is also generally of a toroidal configuration and has acentral aperture 37. Thebase 31 andback portion 36 define a slightly obtuse included angle. In use, theback portion 36 engages the posterior vaginal wall and is supported by the pelvic floor and projects generally toward the cervix from thebase 31. Thebase 31 extends between the posterior and anterior vaginal walls to apply supporting pressure thereto. The pressure applied to the posterior vaginal wall is distributed over theback portion 36. - Preferably the
devices 30 would be formed of a resilient plastics material. - The above described preferred embodiments described with reference to FIGS.1 to 8 is particularly suited for use by women with incontinence and prolapse with a poor pelvic floor.
- With reference to the preferred embodiment of FIGS.5 to 8, it should be appreciated that the
surface 33 is not only convex as a result of consisting of a curve extending about the center of the aperture 35 (as best seen in FIG. 7) but may also be convex in a plane generally perpendicular thereto as best seen in the cross section of FIG. 8. - The
base 31 has alength 48 of between 35 mm and 55 mm, preferably within the range of 40 mm to 50 mm. Thebase 31 should also have a depth 49 of 1 to 3 cm, preferably 1.5 to 2.5 cm. Still further, thebase 31 should have a thickness 50 of 3 to 6 mm, preferably 4 to 5 mm. - In FIGS.9 to 16 of the accompanying drawings there are schematically depicted
intra-vaginal devices 40 to aid in controlling urinary incontinence. Eachdevice 40 has a base 41 provided with an arcuateforward part 42. Thepart 42 has aconvex surface 43 which applies pressure to the anterior vaginal wall to support the vaginal wall and urethra therebehind. Thebase 31 is of a toroidal configuration having acentral aperture 45. - Projecting generally normal from the
base 41 is aback portion 46 which is generally “oval” in configuration. That is it has elongated sides terminating with an upper arcuate portion. Theback portion 46 has acentral slot 47. Again, thebase 41 is slightly inclined to theback portion 46. - The
base 41 extends between the anterior and posterior vaginal walls to apply pressure thereto. The pressure applied to the posterior vaginal wall is distributed over theback portion 46. Theback portion 46 projects towards the cervix and is supported by the pelvic floor. 5. - The device of FIGS.9 to 16 is suitable for younger women with prolapse and urinary incontinence. Preferably it would be formed of an absorbent material so that it could also act as a tampon.
- It should be appreciated in the embodiment of FIGS.13 to 16 that the
surface 43 is not only convex as a result of consisting of a curve extending about the center of the aperture 35 (as best seen in FIG. 15) but may also be convex in a plane generally perpendicular thereto as best seen in FIG. 14. - The
base 41 has alength 48 of between 35 mm and 55 mm, preferably within the range of 40 mm to 50 mm. The base 41 should also have a depth 49 of 1 to 3 cm, preferably 1.5 to 2.5 cm. Still further, thebase 41 should have a thickness 50 of 3 to 6 mm, preferably 4 to 5 mm. - The
rear surface 44 is also provided with anenlarged part 51 which is formed by shaping therear surface 44 so as to be convex when viewed in side elevation (as best seen in FIG. 14). Therear surface 44, which engage the rear posterior vaginal wall, is also arcuate so as to be convex in a plane normal to theback portion 46. - The above two described embodiments address urinary incontinence problems previously ameliorated by urethra pexy or sling procedure.
- The above two described embodiments address the
surfaces dimensions 48 and 49 are arranged such that the force applied to 6. the anterior vaginal wall is distributed to the extend that the urethra is not occluded but merely elevated and supported. - FIG. 17 illustrates the normal anatomy of the urinary system of a female patient. Shown in FIG. 17 are the
symphysis pubis 60;bladder 62 withbladder neck 64;urethra 66;pelvic floor 68;vagina 70 with anteriorvaginal wall 72 and posteriorvaginal wall 74; anduterus 76. Above thepelvic floor 68 is theabdominal cavity 78, with thevaginal cavity 80 lying below the pelvic floor. - Of particular note in FIG. 17 is the position of the
bladder neck 64. Thebladder 62 is located such that thebladder neck 64 is positioned above thepelvic floor 68. Theupper portion 84 of the urethra 66 lies within theabdominal cavity 78, and thelower portion 86 of the urethra lies within thevaginal cavity 80. As a consequence of theupper portion 84 of the urethra 66 lying within theabdominal cavity 78, when dynamic abdominal pressure is exerted, such as by exercise or by coughing, the abdominal pressure is exerted not only-on thebladder 62 but also on theupper portion 84 of theurethra 66. This transient pressure on theupper portion 84 of the urethra 66 balances the pressure exerted on thebladder 62 and thus helps prevent the leakage of urine despite transient increased bladder pressure. - In FIG. 18, the
bladder neck 64 has descended to a location at or below thepelvic floor 68. Theentire urethra 66 lies within thevaginal cavity 80. In this condition, when dynamic abdominal pressure is exerted, because theupper portion 84 of the urethra 66 no longer lies within theabdominal cavity 78, there is no increased pressure exerted on the urethra 66 to offset the transient increased bladder pressure. Consequently, urine will leak when dynamic abdominal pressure 7. is exerted, a condition known as stress urinary incontinence. - It will be appreciated that the condition illustrated in FIG. 18 can be either a static condition, such as when a cystocele condition exists, or a dynamic condition, which exists only in response to increased abdominal pressure. In a patient suffering the latter condition, the normal position of the
bladder neck 64 in the absence of increased abdominal pressure may resemble that shown in FIG. 18. However, because of inadequate support, under increased abdominal pressure thebladder neck 64 will momentarily descend to a location at or below thepelvic floor 68, with the urine leakage consequences described above. - FIG. 19 shows the
device 40 installed to correct improper position of theurethra 66. While the figures show the use of thedevice 40, it is to be understood that thedevice 30 is installed and functions in the same general manner as to thedevice 40. - The
back portion 46 of thedevice 40 rests on the posteriorvaginal wall 74. The length and configuration of theback portion 46 of the device prevents the device from rotating or otherwise becoming displaced within thevagina 70. The lower end of thedevice 40 rests on thepelvic floor 68. With thedevice 40 installed in this position, the convexforward surface 43 of thebase 41 of the device displaces the anteriorvaginal wall 72 forward and upward to support theurethra 66. This support stabilises a hypermobile urethra such that theupper portion 84 of theurethra 66 is retained within theabdominal cavity 78. Consequently, when a dynamic abdominal pressure is exerted, a portion of the abdominal pressure is applied against theupper portion 84 of theurethra 66, which provides an additional force to offset transient 8. bladder pressure increases. - In most adult female patients, it has been found that a
device 40 in which thebase 41 has a length 48 (see FIG. 14) of 35-55 millimeters, and most often 40-50 millimeters, will elevate theanterior wall 72 of thevagina 70 sufficiently to support the urethra 66 in the desired position. However, it will be appreciated that thelength 48 of thedevice 40 needed to accomplish this result will depend on the physiology of the particular female patient, such that devices having a height of greater than 55 millimeters or less than 35 millimeters may be necessary to elevate the anteriorvaginal wall 72 to support the urethra 66 in the proper position without occluding it. so long as theupper portion 84 of theurethra 66 is supported above the anterior segment of thepelvic floor 68 in a retropubic intra-abdominal position, continence should be achieved, thereby correcting hypermobility and augmenting urethrae support. - As will be appreciated, the purpose of the
devices urethra 66 without occluding it. Since exerting a force at single point along the length of theurethra 66 tends to have an occlusive effect, it is desirable to spread the support along a length of the urethra. Since the length of theurethra 66 of an adult female tends to be approximately 3 centimeters, an effective depth 49 (FIG. 14) for the convexforward end 43 of thebase 41 of thedevice 40 has been found to be approximately 2.5 centimeters. However, it will be appreciated that adevice forward edge 43 with a depth of as little as 1 centimeter may produce acceptable results, so long as the effect of the supporting edge is to elevate the urethra to a retropubic intra-abdominal position without occluding it. 9.
Claims (17)
Applications Claiming Priority (11)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/AU1997/000186 WO1997034550A1 (en) | 1996-03-20 | 1997-03-20 | An intra-vaginal device |
USPCTAU9700186 | 1997-03-20 | ||
AUP08796 | 1997-08-27 | ||
AUPO8796A AUPO879697A0 (en) | 1997-08-27 | 1997-08-27 | An intra-vaginal device |
AUPO8796 | 1997-08-27 | ||
AU97/00186 | 1997-09-19 | ||
AUPO9323 | 1997-09-19 | ||
AUPO9323A AUPO932397A0 (en) | 1997-09-19 | 1997-09-19 | An intra-vaginal device |
USPCTAU9800183 | 1998-03-20 | ||
PCT/AU1998/000183 WO1998042281A1 (en) | 1997-03-20 | 1998-03-20 | An intra-vaginal device |
AU98/00183 | 1998-03-20 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/AU1998/000183 Continuation WO1998042281A1 (en) | 1997-03-20 | 1998-03-20 | An intra-vaginal device |
Publications (2)
Publication Number | Publication Date |
---|---|
US20020007106A1 true US20020007106A1 (en) | 2002-01-17 |
US6413206B2 US6413206B2 (en) | 2002-07-02 |
Family
ID=25645588
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/197,736 Expired - Fee Related US6413206B2 (en) | 1997-03-20 | 1998-11-20 | Intra-vaginal device |
Country Status (6)
Country | Link |
---|---|
US (1) | US6413206B2 (en) |
EP (1) | EP0923357B1 (en) |
JP (1) | JP2000510757A (en) |
AT (1) | ATE299357T1 (en) |
AU (1) | AU750463B2 (en) |
WO (1) | WO1998042281A1 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050027565A1 (en) * | 2003-06-23 | 2005-02-03 | John Sader | Motivational method for helping substance abusers quit substance abuse |
WO2012006670A1 (en) * | 2010-07-13 | 2012-01-19 | Contiform International Pty Ltd | Intra-vaginal incontinence device and an applicator for same |
US20220071800A1 (en) * | 2015-08-20 | 2022-03-10 | Watkins-Conti Products, Inc. | Flexible cone-shaped intra-vaginal support device |
EP2793779B1 (en) * | 2011-12-20 | 2022-09-14 | Kimberly-Clark Worldwide, Inc. | Vaginal insert device having perpendicular segments |
Families Citing this family (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6503190B1 (en) | 2000-09-29 | 2003-01-07 | Ethicon Endo-Surgery, Inc. | Vaginal pessary |
US6558370B2 (en) | 2001-06-05 | 2003-05-06 | Kimberly-Clark Worldwide, Inc. | Urinary incontinence device |
US6808485B2 (en) * | 2002-12-23 | 2004-10-26 | Kimberly-Clark Worldwide, Inc. | Compressible resilient incontinence insert |
JP2007529261A (en) | 2004-03-18 | 2007-10-25 | コンティピ リミテッド | Female pelvic organ prolapse treatment device |
ATE499902T1 (en) | 2004-03-18 | 2011-03-15 | Contipi Ltd | DEVICE FOR PREVENTING URINARY INCONTINENCE IN WOMEN |
MX345807B (en) | 2005-03-17 | 2017-02-15 | Kimberly-Clark Worldwide Inc * | Apparatuses for the amelioration of urinary incontinence in females. |
IL176883A (en) | 2005-09-22 | 2013-09-30 | Eliahu Eliachar | Apparatus for the amelioration of urinary incontinence in females |
US10004584B2 (en) | 2006-07-10 | 2018-06-26 | First Quality Hygienic, Inc. | Resilient intravaginal device |
US10219884B2 (en) | 2006-07-10 | 2019-03-05 | First Quality Hygienic, Inc. | Resilient device |
WO2008152628A1 (en) * | 2007-06-11 | 2008-12-18 | Contipi Ltd. | Adjustable tension ring for amelioration of urinary incontinence in females |
WO2009044394A2 (en) | 2007-10-01 | 2009-04-09 | Contipi Ltd. | Management of urinary incontinence in females |
US8651109B2 (en) | 2008-04-23 | 2014-02-18 | Contipi Ltd. | Pessaries for prolapse alleviation |
US20120271098A1 (en) | 2009-11-24 | 2012-10-25 | Elan Ziv | Apparatuses for the treatment of urinary stress and urge incontinence |
US9211211B2 (en) * | 2010-02-02 | 2015-12-15 | Neil Luke Maurette | Female posterior wall prosthesis |
US20120259163A1 (en) | 2011-04-11 | 2012-10-11 | Nancy Karapasha | Method for treating urinary incontinence |
US9078726B2 (en) | 2011-04-11 | 2015-07-14 | The Procter & Gamble Company | Pessary device with longitudinal flexibility |
US20150112231A1 (en) | 2011-11-28 | 2015-04-23 | Remendium Labs Llc | Treatment of fecal incontinence |
US9744630B2 (en) | 2012-06-29 | 2017-08-29 | The Procter & Gamble Company | Method of conforming an overwrap to a pessary device |
US11426625B2 (en) | 2014-01-06 | 2022-08-30 | Remendium Labs Llc | System and method for optimizing pelvic floor muscle training |
US10201411B2 (en) | 2015-06-29 | 2019-02-12 | The Procter & Gamble Company | Pessary with applicator |
BR112018002939A2 (en) | 2015-08-12 | 2019-03-19 | Innoventions Ltd | system for treating a weak or leaking sphincter and system for inducing muscle tissue formation in an organ of the body |
BR112019001393B1 (en) | 2016-07-25 | 2023-04-25 | Ovala, Inc | INCONTINENCE DEVICE |
ES2842380T3 (en) | 2016-07-25 | 2021-07-13 | Ovala Inc | Incontinence device |
SG11201900783PA (en) | 2016-07-29 | 2019-02-27 | Renovia Inc | Devices, systems, and methods for training pelvic floor muscles |
EP4074284A3 (en) | 2017-01-24 | 2022-10-26 | Liv Labs Inc. | Stress urinary incontinence (sui) device |
BR112019020676A2 (en) | 2017-04-26 | 2020-05-12 | Rinovum Subsidiary 2, LLC | INTRODUCER OF URINARY INCONTINENCE DEVICE AND METHOD OF INTRODUCTION OF THE SAME |
USD833009S1 (en) | 2017-07-24 | 2018-11-06 | Rinovum Subsidiary 2, LLC | Incontinence device |
USD832437S1 (en) | 2017-07-24 | 2018-10-30 | Rinovum Subsidiary 2, LLC | Incontinence device |
WO2019178570A1 (en) | 2018-03-16 | 2019-09-19 | Watkins-Conti Products, Inc. | Intravaginal support devices and methods |
USD888948S1 (en) * | 2019-04-02 | 2020-06-30 | Renovia Inc. | Intravaginal device |
USD888949S1 (en) * | 2019-04-03 | 2020-06-30 | Renovia Inc. | Intravaginal device |
USD898911S1 (en) | 2019-04-03 | 2020-10-13 | Renovia Inc. | Intravaginal device assembly |
USD889649S1 (en) * | 2019-04-05 | 2020-07-07 | Renovia Inc. | Intravaginal device |
USD896958S1 (en) * | 2019-04-11 | 2020-09-22 | Renovia Inc. | Intravaginal device |
USD899593S1 (en) * | 2019-04-12 | 2020-10-20 | Renovia Inc. | Intravaginal device |
USD896959S1 (en) * | 2019-04-23 | 2020-09-22 | Renovia Inc. | Intravaginal device |
USD897530S1 (en) * | 2019-04-23 | 2020-09-29 | Renovia Inc. | Intravaginal device |
WO2021142537A1 (en) | 2020-01-14 | 2021-07-22 | Cntrl+ Inc. | Intravaginal device |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1790801A (en) * | 1931-02-03 | Louis dickstehst | ||
US4139006A (en) * | 1977-03-18 | 1979-02-13 | Corey Arthur E | Female incontinence device |
US4920986A (en) | 1986-10-14 | 1990-05-01 | Zedlani Pty. Limited | Urinary incontinence device |
US5386836A (en) * | 1986-10-14 | 1995-02-07 | Zedlani Pty Limited | Urinary incontinence device |
DE3720858A1 (en) * | 1987-06-24 | 1989-01-05 | Thomas Moenks | Device for the treatment of urinary incontinence in women |
EP0460807A3 (en) * | 1990-05-03 | 1992-01-08 | Zedlani Pty. Limited | Urinary incontinence device |
FR2698781B1 (en) * | 1992-12-07 | 1995-04-07 | Chanez Jean Francois | Device intended to remedy light urinary incontinence in women. |
DK95193D0 (en) * | 1993-08-20 | 1993-08-20 | Coloplast As | DEVELOPMENT TO PREVENT UNLOCKED WATER |
US5609559A (en) * | 1995-05-15 | 1997-03-11 | Weitzner; Howard B. | Device for female patients to prevent involuntary loss of urine |
AU2019097A (en) * | 1996-03-20 | 1997-10-10 | Niquoola Pty. Ltd. | An intra-vaginal device |
-
1998
- 1998-03-20 EP EP98907774A patent/EP0923357B1/en not_active Expired - Lifetime
- 1998-03-20 AT AT98907774T patent/ATE299357T1/en not_active IP Right Cessation
- 1998-03-20 WO PCT/AU1998/000183 patent/WO1998042281A1/en active IP Right Grant
- 1998-03-20 AU AU66043/98A patent/AU750463B2/en not_active Ceased
- 1998-03-20 JP JP10544531A patent/JP2000510757A/en active Pending
- 1998-11-20 US US09/197,736 patent/US6413206B2/en not_active Expired - Fee Related
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050027565A1 (en) * | 2003-06-23 | 2005-02-03 | John Sader | Motivational method for helping substance abusers quit substance abuse |
WO2012006670A1 (en) * | 2010-07-13 | 2012-01-19 | Contiform International Pty Ltd | Intra-vaginal incontinence device and an applicator for same |
EP2793779B1 (en) * | 2011-12-20 | 2022-09-14 | Kimberly-Clark Worldwide, Inc. | Vaginal insert device having perpendicular segments |
US20220071800A1 (en) * | 2015-08-20 | 2022-03-10 | Watkins-Conti Products, Inc. | Flexible cone-shaped intra-vaginal support device |
Also Published As
Publication number | Publication date |
---|---|
EP0923357A4 (en) | 2000-06-14 |
WO1998042281A9 (en) | 1999-03-25 |
WO1998042281A1 (en) | 1998-10-01 |
US6413206B2 (en) | 2002-07-02 |
AU750463B2 (en) | 2002-07-18 |
EP0923357A1 (en) | 1999-06-23 |
ATE299357T1 (en) | 2005-07-15 |
AU6604398A (en) | 1998-10-20 |
EP0923357B1 (en) | 2005-07-13 |
JP2000510757A (en) | 2000-08-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6413206B2 (en) | Intra-vaginal device | |
CA1322913C (en) | Urinary incontinence device | |
US5386836A (en) | Urinary incontinence device | |
US10405959B2 (en) | Apparatus for the prevention of urinary incontinence in females | |
KR101040414B1 (en) | C-shaped vaginal incontinence insert | |
US6189535B1 (en) | Deflatable vaginal pessary | |
US20020083949A1 (en) | Female incontinence control device | |
GR3031353T3 (en) | Selective system scan for multizone radiotelephone subscriber units. | |
CA2477834A1 (en) | Method and apparatus for treating pelvic organ prolapses in female patients | |
WO1997034550A1 (en) | An intra-vaginal device | |
EP0460807A2 (en) | Urinary incontinence device | |
MXPA98009687A (en) | An intra-vaginal device | |
AU606408B2 (en) | Female incontinence device | |
IL86078A (en) | Urinary incontinence device | |
IE62880B1 (en) | Urinary incontinence device | |
US20020166560A1 (en) | Feminine urinary incontinence inhibitor interlabial device | |
NZ224254A (en) | Intra-vaginal urinary incontinence control device | |
NZ222169A (en) | Intra-vaginal, urinary incontinence control device |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: NIQUOOLA PTY LTD, AUSTRALIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:BISWAS, NICHOLAS;REEL/FRAME:009892/0998 Effective date: 19990316 |
|
REMI | Maintenance fee reminder mailed | ||
REIN | Reinstatement after maintenance fee payment confirmed | ||
FP | Lapsed due to failure to pay maintenance fee |
Effective date: 20060702 |
|
FEPP | Fee payment procedure |
Free format text: PETITION RELATED TO MAINTENANCE FEES FILED (ORIGINAL EVENT CODE: PMFP); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY |
|
FEPP | Fee payment procedure |
Free format text: PETITION RELATED TO MAINTENANCE FEES GRANTED (ORIGINAL EVENT CODE: PMFG); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY |
|
FPAY | Fee payment |
Year of fee payment: 4 |
|
SULP | Surcharge for late payment | ||
PRDP | Patent reinstated due to the acceptance of a late maintenance fee |
Effective date: 20080326 |
|
REMI | Maintenance fee reminder mailed | ||
FPAY | Fee payment |
Year of fee payment: 8 |
|
SULP | Surcharge for late payment |
Year of fee payment: 7 |
|
REMI | Maintenance fee reminder mailed | ||
LAPS | Lapse for failure to pay maintenance fees | ||
STCH | Information on status: patent discontinuation |
Free format text: PATENT EXPIRED DUE TO NONPAYMENT OF MAINTENANCE FEES UNDER 37 CFR 1.362 |
|
FP | Lapsed due to failure to pay maintenance fee |
Effective date: 20140702 |